Solid biosciences to participate at the 2024 cantor global healthcare conference

Charlestown, mass., sept. 12, 2024 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company” or “solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that bo cumbo, president and ceo, and gabriel brooks, m.d., chief medical officer, will participate in a fireside chat at the 2024 cantor global healthcare conference on wednesday, september 18, 2024, at 10:20 am et.
SLDB Ratings Summary
SLDB Quant Ranking